Pharmaceutical Product Procurement for Indian Army

The Department of Military Affairs, under the Ministry of Defence, is pleased to announce an open tender for the procurement of a comprehensive range of pharmaceutical products. This vital tender, identified by Bid Number GEM/2026/B/8142564, is being issued by the Indian Army and opens for submissions on November 3rd, 2026, at 8:45 AM, concluding on November 13th, 2026, at 9:00 AM. The total estimated quantity for this requirement is 427,848 units. The scope of supply encompasses a broad spectrum of medications, including but not limited to, activated charcoal, fungal diastase, papain, bisacodyl, ursodeoxycholic acid, esomeprazole, clarithromycin, amoxicillin, glycopyrrolate, ondansetron, pancreatin microspheres, pantoprazole, domperidone, itopride, levosulpiride, prochlorperazine, prucalopride, rabeprazole, racecadotril, ranitidine, saccharomyces boulardii, hyoscine butylbromide injection, dicyclomine injection, metoclopramide injection, isabgol (ispaghula husk), lansoprazole, alfuzosin, bethanechol, finasteride, and flavoxate. All interested and eligible bidders are invited to participate in this significant procurement opportunity for the provision of these essential pharmaceutical supplies.